To receive cancer treatment, patients must apply to the V. A. Fanarjyan National Oncology Center.

Eligibility Requirements

The program is open to all patients based on medical indications, regardless of social or special group status. At least one of the following conditions must be met:

• Metastatic colorectal cancer in combination with fluoropyrimidine derivatives
• Non-small-cell and non-squamous-cell lung cancer in locally advanced (non-operable), recurrent, or metastatic stages as first-line therapy combined with chemotherapy and immunotherapy
• Locally advanced or metastatic renal cell carcinoma as monotherapy
• Malignant brain tumors, specifically WHO grade 3 and 4 astrocytomas and glioblastomas, as monotherapy or in combination with chemotherapy
• Primary cancers of the ovaries, fallopian tubes, and peritoneum
• Stage IV cervical cancer in combination with chemotherapy
• Hepatocellular carcinoma in locally advanced and metastatic stages as first-line therapy combined with immunotherapy

Required Documents

To receive cancer treatment, the following must be submitted:

• Patient’s medical history (epicrisis) including information on cancer staging
• Patient’s passport or ID card
• Contact details

If the clinical stage meets the eligibility criteria, additional documents may be required:

• Description of the medical history and examination
• CT scan, and if necessary, MRI and/or PET-CT results
• Pathohistological tumor data
• Immunohistochemical tumor data, if needed
• For patients with comorbidities, additional tests may be performed to evaluate overall health status, prevent or monitor possible side effects of the medication:
• Complete blood count
• Comprehensive metabolic panel including liver and kidney function tests

Support Provided

Based on medical indications, all eligible patients are provided with Mvasi (Bevacizumab) intravenous solution 25mg/ml – 16ml and 4ml vials.

Provision Procedure and Timeline

Service provision timelines are determined by the medical institution.

Attention

Patients who have received treatment in Yerevan medical institutions and wish to continue treatment in another region or community can do so only if:

• The preferred medical institution provides treatment for the condition under the state order.
• Radiation therapy will not be required during the course of treatment (since it is available only in Yerevan).

Reference to Legislation
Order N 1227-L of the RA Minister of Health, March 6, 2024
The order is available on the RA Ministry of Health website at moh.am.